AWAKN LIFE SCIENCES
Awakn Life Sciences is a biotechnology company with clinical operations that develops and delivers psychedelic medicine to better treat addiction. Awakn's team consists of chemists, scientists, psychiatrists, and psychologists who are developing and advancing the next generation of psychedelic drugs, therapies, and enabling technologies to treat addiction.
AWAKN LIFE SCIENCES
Industry:
Biotechnology Health Care Life Science
Founded:
2020-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.awaknlifesciences.com
Total Employee:
101+
Status:
Active
Contact:
416-907-5644
Total Funding:
11.43 M USD
Technology used in webpage:
Google Google Cloud YouTube Google Search Appliance Unsplash CookieYes For WordPress
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-16 | Axon klinikken | Axon klinikken acquired by Awakn Life Sciences | N/A |
Investors List
Mystic Ventures
Mystic Ventures investment in Post-IPO Equity - Awakn Life Sciences
TD Veen
TD Veen investment in Post-IPO Debt - Awakn Life Sciences
National Institute for Health Research
National Institute for Health Research investment in Grant - Awakn Life Sciences
Innovate UK
Innovate UK investment in Grant - Awakn Life Sciences
Negev Capital
Negev Capital investment in Funding Round - Awakn Life Sciences
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-07 | Awakn Life Sciences Appoints Biotech and Investment Veteran Dennis Purcell as a Special Advisor to the CEO |
Official Site Inspections
http://www.awaknlifesciences.com Semrush global rank: 9.76 M Semrush visits lastest month: 320
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Awakn Life Sciences"
Team - Awakn Life Sciences
MAIN OFFICE Awakn Life Sciences Corp 301-217 Queen St. W Toronto, Ontario M5V 0R2 CanadaSee details»
Corporate Presentation - awaknlifesciences.com
AwaknLifeSciences.com 3. 40m with AUD in UK, US, and EU4 90% untreated 75% of treated relapse within 12 months Significant Addressable Market for AUD. Efficacy Proven for Severe …See details»
Awakn Life Sciences - Crunchbase Company Profile
Awakn Life Sciences is a biotechnology company with clinical operations that develops and delivers psychedelic medicine to better treat addiction.See details»
AWKNF - Awakn Life Sciences Corp. | Company Profile | OTC Markets
Dec 13, 2024 awaknlifesciences.com +1 416-270-9566. ... Scorsis, formerly President of Red Bull Canada, was instrumental in restructuring the organization from a geographical and …See details»
Awakn Life Sciences Corp. - Canadian Securities Exchange
Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing medication-assisted treatments for addiction. Awakn has a near-term focus on Alcohol Use Disorder …See details»
Company Information - RocketReach
Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders. Awakn has a near-term focus on Alcohol Use …See details»
Awakn Life Sciences - LinkedIn
Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders. Awakn has a near-term focus on Alcohol Use …See details»
Awakn Life Sciences - Psychedelic Invest
Awakn Life Sciences is a biotechnology company with clinical operations; researching, developing, and delivering psychedelic medicine to better treat Addiction. Awakn’s team …See details»
Awakn Life Sciences - Overview, News & Similar companies
Nov 15, 2023 Awakn Life Sciences contact info: Phone number: (416) 907-5644 Website: www.awaknlifesciences.com What does Awakn Life Sciences do? Awakn Life Sciences is a …See details»
Team - Awakn Clinics
Awakn Clinics London 18 Dukes Road, WC1H 9PY, London, United Kingdom Phone: +44 207 387 2596 [email protected]See details»
Awakn Life Sciences Corp, AWKNF:PKC profile - FT.com
Feb 25, 2025 Awakn Life Sciences Corp. is a Canada-based clinical-stage biotechnology company. The Company is developing therapeutics for substance use and mental health …See details»
About Addiction - Awakn Life Sciences
Addiction is one of the biggest unmet medical needs globally. Substance addiction affects over 20%¹ of the global adult population – that’s more than 1.3 billion people!See details»
Awakn Life Sciences Signs Second Licensing Partnership …
Aug 18, 2022 Licensing Partnership with Wellbeings(R) marks entry into Canadian addiction treatment and relapse prevention market Toronto, Ontario--(Newsfile Corp. - August 18, 2022) …See details»
Awakn Life Sciences Corp. (AWKNF) - Yahoo Finance Canada
Find the latest Awakn Life Sciences Corp. (AWKNF) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Awakn Life Sciences Provides Update on R&D Programs, …
Jan 27, 2025 Toronto, Ontario--(Newsfile Corp. - January 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage …See details»
Research & Development - Awakn Life Sciences
Overview: AWKN-SDN-14 are a series of serotonin, dopamine, and noradrenaline modulators under pre-clinical investigation by Awakn. Being assessed for potential to promote pro-social …See details»
Awakn Life Sciences Announces Listing on the Canadian Securities …
Feb 12, 2024 Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology …See details»
Establishing Canada’s first large-scale bioinnovation centre
1 day ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»
John Papastergiou - Awakn Life Sciences
MAIN OFFICE Awakn Life Sciences Corp 301-217 Queen St. W Toronto, Ontario M5V 0R2 CanadaSee details»
Awakn Life Sciences Announces Launch of Licensing Partnership …
Apr 3, 2024 Awakn also announces Private Placement Toronto, Ontario--(Newsfile Corp. - April 3, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" …See details»